Tag: Competition

Displaying 1541 - 1560 of 2925 results.

Pages

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Honeywell International, Inc.’s acquisition of rival scan engine manufacturer Intermec Inc. was anticompetitive. The FTC’s complaint charged that the proposed acquisition would reduce...
The market for fuel ethanol in the United States is unconcentrated, with 156 firms nationwide either producing ethanol or likely to begin producing ethanol in the next 12 to 18 months, according to the Federal Trade Commission’s 2013 Report on the State of U.S. Ethanol Production. The lack of...
The Federal Trade Commission has extended the deadline for public comments on its proposed study of patent assertion entities (PAEs), which it announced on September 27.  To provide additional time for interested parties to submit comments on the proposed study, the deadline has been extended...
The Federal Trade Commission today launched a redesigned FTC.gov website that’s easier to use and reader friendly on tablets and smart phones. Users can now sort FTC cases, early termination notices for merger investigations, advocacy filings and other documents by date, type, and more. In addition...
Following a public comment period, the Federal Trade Commission has approved an application by Pinnacle Entertainment, Inc. to divest all of the assets associated with Ameristar Casinos, Inc.’s casino and hotel project under construction in Lake Charles, Louisiana to GNLC Holdings, Inc., the parent...
Related: Prepared Statement of the Federal Trade Commission and Testimony
Federal Trade Commission Chairwoman Edith Ramirez announced the appointments of Latanya Sweeney as the agency’s Chief Technologist and Andrea Matwyshyn as a Senior Policy Advisor on privacy and data security issues.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires that brand-name drug manufacturers and generic drug applicants file certain agreements with the FTC and the Department of Justice.  This page presents information related to the filing process, as well...
In testimony presented to a U.S. House of Representatives Judiciary subcommittee the Federal Trade Commission described its ongoing efforts to protect competition and consumers in many important sectors of the economy, including health care, pharmaceuticals, and technology.
The Federal Trade Commission held a workshop to explore competition issues involving biologic medicines and follow-on biologics. As described in the Federal Register Notice, the workshop focused on a few key issues, inter alia:
Series of hearings: December 5, 2008 February 11-12, 2009 March 18-19, 2009 April 17, 2009 May 4-5, 2009
The FTC challenged Ardagh Group, S.A.’s proposed $1.7 billion acquisition of Saint-Gobain Containers, Inc., alleging that it will reduce competition and result in the two firms – the merged firm and its only remaining significant competitor, Owens-Illinois – controlling in excess of...
The Federal Trade Commission will host a one-day public workshop on December 10, 2013, at its headquarters in Washington, DC, to examine competition issues surrounding biologic and follow-on biologic medications.

Pages